Intratumoral versus Circulating Lymphoid Cells as Predictive Biomarkers in Lung Cancer Patients Treated with Immune Checkpoint Inhibitors: Is the Easiest Path the Best One?

The molecular and cell determinants that modulate immune checkpoint (ICI) efficacy in lung cancer are still not well understood. However, there is a necessity to select those patients that will most benefit from these new treatments. Recent studies suggest the presence and/or the relative balance of...

Descripción completa

Detalles Bibliográficos
Autores principales: Gascón, Marta, Isla, Dolores, Cruellas, Mara, Gálvez, Eva M., Lastra, Rodrigo, Ocáriz, Maitane, Paño, José Ramón, Ramírez, Ariel, Sesma, Andrea, Torres-Ramón, Irene, Yubero, Alfonso, Pardo, Julián, Martínez-Lostao, Luis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348938/
https://www.ncbi.nlm.nih.gov/pubmed/32580514
http://dx.doi.org/10.3390/cells9061525

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348938/
https://www.ncbi.nlm.nih.gov/pubmed/32580514
http://dx.doi.org/10.3390/cells9061525

Ejemplares similares